RWML
ALDX icon

RAFFA WEALTH MANAGEMENT, LLC’s Aldeyra Therapeutics ALDX Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.04K Hold
1,897
– – ﹤0.01% 643
2026
Q1 		$3.21K Hold
1,897
– – ﹤0.01% 638
2025
Q4 		$9.83K Hold
1,897
– – ﹤0.01% 382
2025
Q3 		$9.9K Hold
1,897
– – ﹤0.01% 366
2025
Q2 		$7.27K Hold
1,897
– – ﹤0.01% 441
2025
Q1 		$10.9K Hold
1,897
– – ﹤0.01% 299
2024
Q4 		$9.47K Buy
+1,897
New +$9.73K ﹤0.01% 337

Other funds holding ALDX

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's ALDX Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC held its Aldeyra Therapeutics (ALDX) position steady in Q2 2026 at 1,897 shares worth $4.04K. The position accounts for ﹤0.01% of the portfolio, ranked #643.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in ALDX in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.9K in Q1 2025. 18 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 1,897 shares of Aldeyra Therapeutics worth $4.04K as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC left its Aldeyra Therapeutics share count unchanged in Q2 2026.
  • Aldeyra Therapeutics made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #643 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Aldeyra Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • RAFFA WEALTH MANAGEMENT, LLC's Aldeyra Therapeutics position peaked at $10.9K in Q1 2025.
  • 18 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.